Humana (NYSE:HUM) Price Target Lowered to $200.00 at Truist Financial

NodeGuardian · 2026-02-26T15:18:37+00:00

Truist Financial reduced its price target for Humana to $200, maintaining a "hold" rating, despite the company exceeding quarterly EPS estimates and showing strong revenue growth, with a FY2026 guidance of 9.00 EPS.

NodeGuardian

2026-02-26 15:18:37

Abstract generation in progress

Truist Financial has lowered its price target for Humana (NYSE:HUM) from $285.00 to $200.00, maintaining a “hold” rating, which suggests an 8.32% upside from its current price. This revision follows several other firms, including Goldman Sachs and Leerink, also cutting their price targets for the insurance provider. Despite these adjustments, Humana slightly surpassed quarterly EPS estimates and reported robust revenue growth, and the company set its FY2026 guidance at 9.00 EPS.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.